Navigation Links
NxStage(R) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
Date:2/3/2010

LAWRENCE, Mass., Feb. 3 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that it signed a five-year exclusive distribution agreement with Nordic Medcom AB, a distributor of renal care products in Sweden, Denmark, Finland and other international healthcare markets, for the promotion, sale, delivery and service of the NxStage System One and certain of the Company's in-center products in Sweden, Denmark and Finland.

Under the terms of the agreement, the NxStage System One and PureFlow SL dialysate preparation system will be available to dialysis centers throughout these countries exclusively through Nordic Medcom. Nordic Medcom also has the option to make Medisystems bloodlines and ButtonHole needles available to their customers in these regions.

"This agreement with Nordic Medcom marks the second international distribution agreement we have signed as we pursue our growth objectives and expand internationally," stated Joseph Turk, Senior Vice President, Commercial Operations of NxStage Medical, Inc.  "To date, our products have been well received by patients and customers in the UK and Ireland.  The combination of Nordic Medcom's experience in the renal care industry, coupled with its strong distribution capabilities within Sweden, Denmark and Finland, provides us with the opportunity to meet growing demand and further broaden access to our life changing therapy for dialysis patients within these regions."

"We believe there is increasing interest in home hemodialysis within this region and are excited to be working with NxStage, the market pioneer," said Arne Puhasmagi, General Manager and President of Nordic Medcom AB.  "We strive to provide our customers with innovative technology that improves patient care. NxStage's focus on innovation and quality makes them a natural addition to our portfolio."

About Nordic Medcom AB

Nordic Medcom AB is a Scandinavian dialysis company with head office in Sweden. Nordic Medcom is focused at dialysis and marketing dialysis catheters, intensive care dialysis – CRRT-treatment, and products for chronic dialysis to hospitals in Sweden, Denmark, Finland, Norway, Iceland and the Baltic states.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of End Stage Renal Disease (ESRD) and acute kidney failure. For more information on NxStage and its products, please visit NxStage's website at www.nxstage.com.  

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including Nordic Medcom AB's ability to successfully promote, sell and service our products, customer demand for our products in the UK , Ireland, Sweden, Denmark and Finland,  and factors that are discussed in NxStage's Quarterly Report on Form 10-Q for the period ended September 30, 2009 filed with the SEC. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

    
    
    NxStage Medical: 
    Kristen K. Sheppard, Esq.
    VP, Investor Relations
    ksheppard@nxstage.com

SOURCE NxStage Medical, Inc.

RELATED LINKS
http://www.nxstage.com

'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM)
2. NxStage(R) Reports Third Quarter 2009 Financial Results and Raises Revenue Guidance for Fiscal 2009
3. NxStage(R) Reports Significant Interim FREEDOM Study Results
4. NxStage(R) to Report Third Quarter 2009 Financial Results
5. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
6. NxStage(R) to Recognize Several Key Milestones at American Society of Nephrologys Renal Week 2007
7. Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
8. Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
9. Bavarian Nordic Enters Clinical Trials with HIV Multiantigen Vaccine
10. ETEX Corporation Announces Distribution Agreement With OrthoPediatrics Corp.
11. Smith & Nephew Orthopaedics Begins Distribution to Haiti of Trauma Implants and Instruments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... May 27, 2016 According to ... hypertension is driving ambulatory blood pressure monitoring system market ... and their ability to respond to different pressure rates, ... can lead to various cardiovascular disorders such as heart ... These diseases are growing in prevalence each year. WHO ...
(Date:5/27/2016)... 27, 2016 Kitov ... focused on late-stage drug development, today announced the ... of pivotal batches required for registration of KIT-302 ... This follows Kitov,s announcement in December ... met its primary efficacy endpoint. "We ...
(Date:5/27/2016)... The healthcare sector is large ... all falling under its umbrella.  A rather overlooked sector ... talked about, these healthcare companies are still trying to ... is by far the largest consumer of the healthcare ... ADMD), Nutranomics Inc. (OTC: NNRX), KollagenX Corp. (OTCQB: KGNX), ...
Breaking Medicine Technology:
(Date:5/31/2016)... ... , ... Psoriasis: Targets and Therapy has published ... author Professor Luigi Naldi says “The review in Psoriasis: Targets and Therapy throws ... onset and the severity of psoriasis, and negatively influences the response to systemic ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... individuals’ genetic characteristics and the physical and behavioral worlds in which they ... In personalized medicine, diagnosing an individual’s disease depends on accurately assessing his ...
(Date:5/31/2016)... ... May 31, 2016 , ... More than 80 representatives of the ... and the Prevent Cancer Foundation held an event on National Hepatitis Testing Day outside ... of viral hepatitis, the leading cause of liver cancer. , Foundation leaders and the ...
(Date:5/31/2016)... ... May 31, 2016 , ... Splashtop Inc., the worldwide leader in high ... Co., the leading provider of secure mobile remote access solution for Japan enterprises. ... CACHATTO remote access solution. Splashtop for CACHATTO will be available as an ...
(Date:5/31/2016)... ... ... Twenty years ago it was revolutionary: enabling the people who hear distressing voices to ... this approach has proven transformative, both for people who hear voices and for the ... used around the world, but it still lags in the United States. , Now, ...
Breaking Medicine News(10 mins):